Vitafoods Europe hosted a record-breaking number of attendees, coming together to identify the emerging trends and advancements of the nutraceutical industry.

Bipartisan legislation introduced in Congress would expand access to dietary supplements by allowing eligible products to be purchased through HSAs, FSAs, and HRAs, a move supporters say better aligns federal policy with preventive health practices.

Explore 11 of the biggest trends from Natural Products Expo West 2026, including protein innovation, gut health, GLP-1 support, regenerative products, clean-label foods, and science-backed wellness, plus that ingredient supplier and brands that deliver on the trends.

Following petitions arguing the ban of ashwagandha leaves or extracts that contain leaf in health supplements bypassed formal regulatory amendment procedures under existing food safety frameworks, The Karnataka High Court has issued an interim stay and scheduled a follow-up hearing.

NPA members brought key supplement policy priorities directly to lawmakers, including concerns over state-level restrictions and mandatory product listing proposals.

A decades-old definition is under the microscope as FDA gathers input on dietary supplement ingredients and innovation.

A new House bill would require dietary supplement manufacturers to register products with FDA, reigniting debate between industry groups over transparency, regulatory burden, and the future of DSHEA oversight.

NOW's latest round of industry quality testing of dietary supplements involved 35 oregano oil supplements sold on Amazon, and found nearly two-thirds failed potency standards.

The Government of India's restriction on ashwagandha leaves in nutritional supplements is sparking industry debate. Experts weigh safety, science, and supply chain impacts of the root-only directive.